Improving Public Health Outcomes through Enhancing Accelerated Access to Care and Treatment Innovation for COVID-19

IMPAACT4C19 Consortium is led by The Aurum Institute in partnership with KNCV Tuberculosis Foundation, Clinton Health Access Initiative and Treatment Action Group. It aims to improve access to COVID-19 related quality and affordable diagnostic and therapeutic tools in 5 countries through policy and regulatory support, technical support to ministries of health, supply chain and procurement assistance, and demand generation in communities. During grant implementation, evidence will be generated to support scale-up and further catalytic uptake in existing countries and beyond.

Latest Covid-19 Guidance

  • Guidance on the use of molnupiravir (Lagevrio)
  • Covid-19 Rapid Antigen Self-Testing - Interim Guidance to African Union Member States
  • Strategic preparedness, readiness and response plan to end the global COVID-19 emergency in 2022
  • Guidance for the use of nirmatrelvir/ritonavir (Paxlovid)
We aim to achieve our objectives by providing access to effective COVID-19 test, triage and treat solutions within healthcare systems through the following areas of focus. 

Evidence Generation

  • Self-testing strategies & packages of care
  • Effectiveness of Self-testing strategies
  • Costing & effectiveness

Supply Chain & Catalytic Implementation

  • Improved access to Diagnostic tools & strategies 
  • Therapeutics & care strategies
  • Improved Utilization of  Digital Health Solutions

Policy Guideline & Regulatory Approval

  • Landscaping of existing strategies
  • Analysis of regulatory pathways
  • Technical support to MOH

Demand Creation for Increased Access

  • Demand Creation through Advocacy groups
  • Developing print & digital material

Effective Transition & Scale-up

  • Forecasting & Quantification for country needs
  • Technical Support to Ministries

Project Countries

2021 - 2022

Milestones and Case Studies